Foamix-Sub-Investigator; A Randomized, Double-Blind, Vehicle Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 for 12 weeks in the treatment of Moderate to Severe Acne Vulgaris

2017-Present

Revance - Sub-Investigator; An Open-Label, Multi- Center Trial to Assess the Safety of Single and Repeat Treatments of DaxibotuliniumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines (SAKURA OPEN LABEL SAFETY)